ADMISSION TO TRADING
Date: 15 September 2026
Company: Malibu Life Holdings Limited
LEI: 549300WXTCG65AQ7V644
Malibu Life Holdings Limited
(the "Company")
Notification of Admission to Trading of Further Securities (PRM 1.6.4R)
Further to the Company’s announcement on 11 September 2026 of the allotment and issue of 84,999 new ordinary shares of US$0.01 each in the Company pursuant to the vesting of certain conditional awards over ordinary shares of US$0.01 each in the Company on 8 June 2026 granted subject to the rules of the Malibu Life Omnibus Incentive Plan, the below information is disclosed in accordance with the PRM 1.6.4R of the Prospectus Rules: Admission to Trading on a Regulated Market sourcebook of the Financial Conduct Authority.
|
|
Details of the issuer | |
|
|
Name | Malibu Life Holdings Limited |
|
|
LEI | 549300WXTCG65AQ7V644 |
|
|
Details of the transferable securities admitted to trading | |
|
|
Name, type and identification code | Ordinary sharesISIN: KYG8827C1006 |
|
|
Regulated Market | London Stock Exchange – Main Market |
|
|
Number of further securities admitted | 84,999 ordinary shares |
|
|
Total number of securities in issue following admission | 25,777,809 ordinary shares |
|
|
Fungibility | Fully fungible with existing ordinary shares |
|
|
Admission details | |
|
|
Date of admission | 15 September 2026 |
|
|
Prospectus information | Prospectus: N/ASupplementary: N/ACompany’s website: https://www.malibulifeinsurance.com/resources/ |
Enquiries
| Company Secretary | +1 (345) 814-7600 |
| Walkers Corporate Limited | |
| Investor Contact | ir@malibulifeinsurance.com |
| Investor relations | (212) 715-6707 |